pioglitazone hydrochloride
Generic: pioglitazone hydrochloride
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
pioglitazone hydrochloride
Generic Name
pioglitazone hydrochloride
Labeler
aurobindo pharma limited
Dosage Form
TABLET
Routes
Active Ingredients
pioglitazone hydrochloride 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65862-513
Product ID
65862-513_75b48749-1268-4752-8a50-83382f05c951
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA200268
Listing Expiration
2026-12-31
Marketing Start
2013-02-13
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65862513
Hyphenated Format
65862-513
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pioglitazone hydrochloride (source: ndc)
Generic Name
pioglitazone hydrochloride (source: ndc)
Application Number
ANDA200268 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/1
Packaging
- 500 TABLET in 1 BOTTLE (65862-513-05)
- 3 BLISTER PACK in 1 CARTON (65862-513-10) / 10 TABLET in 1 BLISTER PACK
- 30 TABLET in 1 BOTTLE (65862-513-30)
- 90 TABLET in 1 BOTTLE (65862-513-90)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "75b48749-1268-4752-8a50-83382f05c951", "openfda": {"upc": ["0365862513106", "0365862513304", "0365862512109", "0365862514103", "0365862512307", "0365862514301"], "unii": ["JQT35NPK6C"], "rxcui": ["312440", "312441", "317573"], "spl_set_id": ["1f259863-21fd-4d62-b094-4eff845944df"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (65862-513-05)", "package_ndc": "65862-513-05", "marketing_start_date": "20130213"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (65862-513-10) / 10 TABLET in 1 BLISTER PACK", "package_ndc": "65862-513-10", "marketing_start_date": "20130213"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (65862-513-30)", "package_ndc": "65862-513-30", "marketing_start_date": "20130213"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (65862-513-90)", "package_ndc": "65862-513-90", "marketing_start_date": "20190614"}], "brand_name": "PIOGLITAZONE HYDROCHLORIDE", "product_id": "65862-513_75b48749-1268-4752-8a50-83382f05c951", "dosage_form": "TABLET", "pharm_class": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "65862-513", "generic_name": "pioglitazone hydrochloride", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PIOGLITAZONE HYDROCHLORIDE", "active_ingredients": [{"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA200268", "marketing_category": "ANDA", "marketing_start_date": "20130213", "listing_expiration_date": "20261231"}